[Gastric acid secretion under the influence of intravenously applicated phenylalanin2-lys8-vasopressin (Octapressin) (author's transl)].
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000032:analysis; D002712:Chlorides / Q000032:analysis; D003864:Depression, Chemical; D005260:Female; D005750:Gastric Juice / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D005753:Gastric Mucosa / Q000098:blood supply / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous; D008239:Lysine; D008274:Magnesium / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010649:Phenylalanine; D011188:Potassium / Q000032:analysis; D012039:Regional Blood Flow; D012964:Sodium / Q000032:analysis; D014667:Vasopressins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*
D002712:Chlorides; D014667:Vasopressins; D010649:Phenylalanine; D012964:Sodium; D008274:Magnesium; D008239:Lysine; D011188:Potassium; D002118:Calcium
Magensäuresekretion unter dem Einfluss von intravenös appliziertem Phenylalanin2-Lys8-Vasopressin (Octapressin)